We have previously observed that the non-opioid morphine metabolite, morphine-3-glu curonide, enhances pain via a toll-like receptor 4 (TLR4) dependent mechanism. The present studies were undertaken to determine whether TLR4-dependent pain enhancement general izes to other classes of glucuronide metabolites. In silico modeling predicted that glucuronic acid alone and ethyl glucuronide, a minor but long-lasting ethanol metabolite, would dock to the same MD-2 portion of the TLR4 receptor complex previously characterized as the docking site for morphine-3-glucuronide. Glucuron ic acid, ethyl glucuronide and ethanol all caused an increase in TLR4-dependent reporter protein expression in a cell line transfected with TLR4 and associated co-signaling molecules. Glucuronic acid-, ethyl glucuronide-, and ethanol-induced increases in TLR4 signaling were blocked by the TLR4 antag onists LPS-RS and (+)-naloxone. Glucuronic acid and ethyl glucuronide both caused allodyni a following intrathecal injection in rats, which was blocked by intrathecal co-administration of the TLR4 antagonist LPS-RS. The finding that ethyl glucuronide can cause TLR4-dependent pain could have implications for human conditions such as hangover headache and alcohol withdrawal hyperalgesia , as well as suggesting that other classes of glucuronide metaboli tes could have similar effect s.
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Introduction
Many drug metabolites are considered inert byproducts, but increasing evidence suggests certain metabolites can have more complex effects. For instance, morphine-3-glucuronide, a morphine metabolite, causes pro-inflammatory responses in the CNS (Komatsu et al., 2009; Lewis et al., 2010 ) . This response induces pain enhancement blocked by broad-spectrum immune inhibitors (e.g. minocycline) as well as the toll-like receptor 4 (TLR4) signaling inhibitor, (+)-naloxone (Lewis et al., 2010 ) . These data raise the question of whether this TLR4-depende nt pain-sensitizing effect is unique to morphine-3-glucuronide, or found more broadly in glucuronidated metabolites .
The pattern recogniti on receptor TLR4 and its co-receptor MD2 are present on many immune cells, including at least microglia in the CNS (Bsibsi et al., 2002 ) . TLR4/MD2 activation initiates a proinflammatory cascade leading to proinflammatory cytokine release (Lehnardt et al., 2003 ) . TLR4 is linked to enhanced pain, including neuropathi c pain (Hutchinson et al., 2008 ) , and decreased morphine analgesia (Hutchinson et al., 2010b ) , in addition to pain induced by morphine-3-glucuronide (Lewis et al., 2010 ) . TLR4/MD2 signaling can be blocked nonstereosel ectively by (+)-and (À)-naloxone as well as by lipopolys accharide made by Rhodobacte r sphaeroides (LPS-RS), a selective TLR4 antagoni st (Hutchinson et al., 2008 (Hutchinson et al., , 2010b .
Several classes of commonly abused drugs have also been linked to increased TLR4 activity. Morphine has been demonstrated to competitive ly bind MD2, thereby inducing TLR4 signaling (Wang et al., 2012 ) . TLR4 inhibition reduces the rewarding affects of morphine and cocaine (Galer et al., 2012; Hutchinson et al., 2012 ) and reduces sedative and ataxic effects of ethanol (EtOH) (Wu et al., 2012 ) . Addition ally, TLR4 knockout mice display reduced ethanol-induced neuroinflammatory damage following chronic alcohol feeding (Pascual et al., 2011 ) and cultured microglia showed TLR4-depende nt increases in proinflammatory cytokine s in response to EtOH (Fernandez-Liza rbe et al., 2009 ) . Intriguingly, none of these studies considered the
